Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Capital Work in Progress

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Capital Work in Progress ₹655 Cr₹306 Cr₹207 Cr₹493 Cr₹670 Cr

What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?

The latest Capital Work in Progress ratio of MANKIND PHARMA is ₹655 Cr based on Mar2026 Consolidated results.
Year Capital Work in Progress
Mar2026₹655 Cr
Mar2025₹306 Cr
Mar2024₹207 Cr
Mar2023₹493 Cr
Mar2022₹670 Cr

How is Capital Work in Progress of MANKIND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2026 ₹655 Cr
113.89
Mar2025 ₹306 Cr
47.82
Mar2024 ₹207 Cr
-58.01
Mar2023 ₹493 Cr
-26.38
Mar2022 ₹670 Cr -

Compare Capital Work in Progress of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹93,957.5 Cr -5.2% 1.2% -4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-5.2%

1.2%

-4.2%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses